RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
RENEW | SUBSCRIBE
Home » Resources » News and Research
Subscribe or renew to PPM

All News and Research Articles

Lilly's Emgality Joins the CGRP Club
FDA approves third migraine prevention medication in the new CGRP class: Lilly's Emgality.
FDA Approves Final Opioid Analgesic Risk Evaluation and Mitigation Strategy
FDA REMS now apply to immediate-release opioid analgesics.
New Quality Improvement Guide for Primary Care Opioid Prescribers
Nearly $200 million in new CDC funds will go to territories, tribes, NGOs, and states to help support opioid awareness and response programs.
Teva's AJOVY Joins Migraine Prevention Meds on the Market
A PPM Brief
Chronic Pain Primary Reason for Misused Prescription Opioids
SAMHSA releases latest statistics on substance misuse including for prescription opioids, heroin, fentanyl, and more.
FDA Approves New Dosage of Buprenorphine/Naloxone Sublingual Film
Agency is taking steps to advance development of new FDA-approved treatments for opioid dependence.
Small Trial Shows Ketamine Activates the Brain’s Opioid System
Stanford scientists discover that ketamine's antidepressive effect is tied to the opioid system in the brain.
FDA Says “Everything is on the Table” Regarding the Development of New Pain Drugs
As the US Congress prepares to return to session after Labor Day, FDA Commissioner Scott Gottlieb, MD, has taken the opportunity to outline his agency’s work on the opioid crisis over the past 8 months.
FDA to Re-Examine Rational Opioid Prescribing, Starting with Acute Pain
FDA tackles opioid epidemic by focusing on rational prescribing practices for the treatment of acute pain.
Buprenorphine Injectable for OUD on its Way
Pennsylvania-based biotech company Braeburn has a PDUFA target date of December 26, 2018 for its buprenorphine injectable aimed at treating opioid use disorder (OUD) in adults.
CGRPs: Your Patients Want To Know More
A new survey shows that migraine sufferers are largely unaware of the new preventive CGRP medication class.
Cleveland Clinic Calls for Partners in Integrative and Lifestyle Interventions
Numerous studies have shown the powerful impact that lifestyle medicine can have on patients as part of an integrative approach.
New Pain Assessment Tool for Chronic Low Back Pain
A new pain assessment tool may be coming soon to clinical trials for better, individualized treatment approaches.
FDA Issues Draft Guidance on Measuring Efficacy of Medication-Assisted OUD Treatment
Agency is encouraging developers to innovate against opioid misuse.
Time to Tip the Scales in Pain Research and Care for Women
PPM's latest special report addresses Pain Research & Care in Women, including:
SHOW MAIN MENU
SHOW SUB MENU